Correlation Between Revelation Biosciences and BioLineRx

Can any of the company-specific risk be diversified away by investing in both Revelation Biosciences and BioLineRx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Revelation Biosciences and BioLineRx into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Revelation Biosciences and BioLineRx, you can compare the effects of market volatilities on Revelation Biosciences and BioLineRx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Revelation Biosciences with a short position of BioLineRx. Check out your portfolio center. Please also check ongoing floating volatility patterns of Revelation Biosciences and BioLineRx.

Diversification Opportunities for Revelation Biosciences and BioLineRx

0.85

Correlation Coefficient

Revelation Biosciences  BioLineRx

Very poor diversification

The 3 months correlation between Revelation and BioLineRx is 0.85. Overlapping area represents the amount of risk that can be diversified away by holding Revelation Biosciences and BioLineRx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioLineRx and Revelation Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Revelation Biosciences are associated (or correlated) with BioLineRx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioLineRx has no effect on the direction of Revelation Biosciences i.e., Revelation Biosciences and BioLineRx go up and down completely randomly.

Pair Corralation between Revelation Biosciences and BioLineRx

Given the investment horizon of 90 days Revelation Biosciences is expected to generate 1.06 times more return on investment than BioLineRx. However, Revelation Biosciences is 1.06 times more volatile than BioLineRx. It trades about 0.2 of its potential returns per unit of risk. BioLineRx is currently generating about -0.13 per unit of risk. If you would invest  45.00  in Revelation Biosciences on October 8, 2024 and sell it today you would earn a total of  19.00  from holding Revelation Biosciences or generate 42.22% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	100.0%
Values	Daily Returns

Revelation Biosciences  vs.  BioLineRx

Revelation Biosciences

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Revelation Biosciences are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Revelation Biosciences sustained solid returns over the last few months and may actually be approaching a breakup point.

BioLineRx

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days BioLineRx has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Revelation Biosciences and BioLineRx

The main advantage of trading using opposite Revelation Biosciences and BioLineRx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Revelation Biosciences position performs unexpectedly, BioLineRx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioLineRx will offset losses from the drop in BioLineRx's long position.

The idea behind Revelation Biosciences and BioLineRx pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.